Our R&D Strategy & Portfolio Optimization service helps biotech and life sciences companies maximize the value of their research investments. We combine scientific evidence, clinical development expertise, and commercial analysis to optimize your R&D portfolio.
How our r&d strategy & portfolio optimization service delivers value to your organization.
Comprehensive asset valuation with phase-specific probability of success and risk-adjusted NPV modeling.
Optimized R&D resource allocation across assets to maximize portfolio value within budget and timeline constraints.
Evaluation of platform technology value and applicability across multiple indications and therapeutic areas.
Assessment of each asset against your corporate strategy, scientific capabilities, and risk tolerance.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Comprehensive audit of current R&D portfolio including assets, stages, and resource allocation.
Risk-adjusted valuation of each asset with probability of success and peak sales estimation.
Portfolio optimization modeling to identify the highest-value resource allocation strategy.
Deliver strategic recommendations with implementation roadmap and performance tracking framework.
We use a combination of comparable analysis, probability of success by therapeutic area, and platform technology valuation methods for early-stage assets.
Yes, we specialize in evaluating platform technology companies, assessing the platform value across multiple potential indications.
Yes, our portfolio analysis supports licensing and business development decisions with asset valuation and strategic fit assessment.
Evaluate new indications with disease burden analysis, treatment landscape mapping, and unmet need quantification across therapeutic areas.
Learn moreComprehensive therapy area deep-dives covering market dynamics, competitive landscape, pipeline products, and emerging trends.
Learn moreMarket analysis for biologics, biosimilars, and advanced therapy medicinal products (ATMPs) with competitive benchmarking.
Learn moreConnect with our team to discuss how our r&d strategy & portfolio optimization service can support your goals.
Schedule a Consultation